Compare iShares MSCI South Africa ETF (EZA) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI South Africa ETF vs TransMedics Group Inc — how do they compare? iShares MSCI South Africa ETF trades at $68.53, while TransMedics Group Inc trades at $87.69 (market cap $3.10B). The key difference: iShares MSCI South Africa ETF is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| EZA | TMDX | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $81.60 | $150.42 |
52-Week Low | $56.57 | $61.99 |
Market Cap | — | $3.10B |
Enterprise Value | — | $3.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EZA trades at $68.43, down 1.86% with technical indicators showing mixed signals. The stock maintains bullish moving averages but faces overbought conditions with RSI readings above 70. Recent dividend declaration of $1.43 for H1-2026 provides income appeal, though fundamental metrics remain undisclosed in current data.
South African market exposure presents both opportunity and risk given current macroeconomic pressures on financials and commodities. The ETF's heavy weighting in gold, banking, and platinum group metals faces headwinds from global reflation trends, requiring careful monitoring of constituent performance.
TransMedics Group (TMDX) trades at $87.42, down 1.12% on the day, with a bullish technical outlook from moving averages but bearish oscillators signaling potential overbought conditions. The company reported mixed Q2 2026 results, missing earnings estimates with EPS of $0.44 versus $0.50 expected, while revenue growth remains robust. Recent news highlights an ongoing investigation into fiduciary duties by directors, adding uncertainty.
The stock presents a cautious opportunity with strong analyst support (69% buy ratings) and a consensus price target of $99.57, implying upside, but risks include earnings volatility, margin pressures, and legal scrutiny. Fundamentals show solid profitability with a 22.69% net margin, though valuation multiples like P/E of 23.15 suggest premium pricing relative to historical norms.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI South Africa ETF
EZA is a country-specific ETF that tracks the South African equity market. It provides exposure to large and mid-cap companies across key sectors like materials and financials, with top holdings such as AngloGold Ashanti and Naspers.
Read more on EZA →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
